FDA Inspection 1170380 — Missouri Baptist Medical Center Blood Bank
The FDA completed an inspection of Missouri Baptist Medical Center Blood Bank on May 13, 2022 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 13, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Saint Louis, MO (United States)